BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12107206)

  • 21. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism.
    Wu FC; Balasubramanian R; Mulders TM; Coelingh-Bennink HJ
    J Clin Endocrinol Metab; 1999 Jan; 84(1):112-22. PubMed ID: 9920070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levonorgestrel enhances spermatogenesis suppression by testosterone with greater alteration in testicular gene expression in men.
    Lue Y; Wang C; Cui Y; Wang X; Sha J; Zhou Z; Xu J; Wang C; Hikim AP; Swerdloff RS
    Biol Reprod; 2009 Mar; 80(3):484-92. PubMed ID: 19074003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis.
    Wang C; Cui YG; Wang XH; Jia Y; Sinha Hikim A; Lue YH; Tong JS; Qian LX; Sha JH; Zhou ZM; Hull L; Leung A; Swerdloff RS
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3292-304. PubMed ID: 17504903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism.
    Schubert M; Minnemann T; Hübler D; Rouskova D; Christoph A; Oettel M; Ernst M; Mellinger U; Krone W; Jockenhövel F
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5429-34. PubMed ID: 15531493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
    Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic analysis of testis biopsies in men treated with injectable testosterone undecanoate alone or in combination with oral levonorgestrel as potential male contraceptive.
    Cui Y; Zhu H; Zhu Y; Guo X; Huo R; Wang X; Tong J; Qian L; Zhou Z; Jia Y; Lue YH; Hikim AS; Wang C; Swerdloff RS; Sha J
    J Proteome Res; 2008 Sep; 7(9):3984-93. PubMed ID: 18702538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone.
    Vaughan C; Goldstein FC; Tenover JL
    J Androl; 2007; 28(6):875-82. PubMed ID: 17609296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P; Lähteenmäki P; Rutanen EM
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrity of the blood-testis barrier in healthy men after suppression of spermatogenesis with testosterone and levonorgestrel.
    Ilani N; Armanious N; Lue YH; Swerdloff RS; Baravarian S; Adler A; Tsang C; Jia Y; Cui YG; Wang XH; Zhou ZM; Sha JH; Wang C
    Hum Reprod; 2012 Dec; 27(12):3403-11. PubMed ID: 23019303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate.
    Anderson RA; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):896-901. PubMed ID: 8772547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levonorgestrel effects on serum androgens, sex hormone-binding globulin levels, hair shaft diameter, and sexual function.
    Kovalevsky G; Ballagh SA; Stanczyk FZ; Lee J; Cooper J; Archer DF
    Fertil Steril; 2010 Apr; 93(6):1997-2003. PubMed ID: 19394598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception.
    Pöllänen P; Nikkanen V; Huhtaniemi I
    Int J Androl; 2001 Dec; 24(6):369-80. PubMed ID: 11737418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
    Gentili A; Mulligan T; Godschalk M; Clore J; Patrie J; Iranmanesh A; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
    Gaussem P; Alhenc-Gelas M; Thomas JL; Bachelot-Loza C; Remones V; Ali FD; Aiach M; Scarabin PY
    Thromb Haemost; 2011 Mar; 105(3):560-7. PubMed ID: 21225090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception.
    Büchter D; von Eckardstein S; von Eckardstein A; Kamischke A; Simoni M; Behre HM; Nieschlag E
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1244-9. PubMed ID: 10199762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men.
    Cherrier MM; Matsumoto AM; Amory JK; Johnson M; Craft S; Peskind ER; Raskind MA
    Psychoneuroendocrinology; 2007 Jan; 32(1):72-9. PubMed ID: 17145137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.